General Updates

Date : 19.06.2026 The Manager The Secretary Listing Department Listing Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, 1st Floor, Phiroze Jeejeebhoy Bandra Kurla Complex, Bandra (East) Towers, Mumbai 400 051 Dalal Street, Maharashtra, India Mumbai 400 001 NSE Symbol: KIMS BSE Scrip Code: 543308 Sub: Qualified institutions placement of equity shares of face value ₹ 2 each (the “Equity Shares”) by Krishna Institute of Medical Sciences Limited (the “Company”) under the provisions of Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the “SEBI ICDR Regulations”), and Sections 42 and 62(1)(c) of the Companies Act, 2013, as amended, including the rules made thereunder (the “Issue”). Dear Madam/ Sir, In furtherance of our earlier letters on the captioned subject, please note that the Finance & Investment Committee at its meeting held today, i.e., June 19, 2026 approved allotment of 1,98,67,549 Equity Shares to eligible qualified institutional buyers at the issue price of ₹ 755 per Equity Share, i.e., at a premium of ₹ 753 per Equity Share (which includes a discount of ₹ 16.73 (2.17% of the floor price) to the floor price), aggregating to approximately ₹ 15,000 million, pursuant to the proposed Issue. Pursuant to the allotment of Equity Shares in the Issue, the paid-up equity share capital of the Company stands increased from ₹ 80,02,77,870 consisting of 40,01,38,935 Equity Shares to ₹ 84,00,12,968 consisting of 42,00,06,484 Equity Shares. The Issue opened on June 16, 2026 and closed on June 19, 2026 and the same was intimated to you through our letters dated June 16, 2026 and June 19, 2026, respectively. Further, find attached herewith the list of allottees who have been allotted more than five percent of the Equity Shares offered in the Issue, marked as Annexure A. The information as required under Regulation 30 of SEBI Listing Regulations read with Schedule – III Part- A to the SEBI Listing Regulations and Chapter V of SEBI Master circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11 November, 2024, each as amended is as follows: Type of securities issued and allotted Equity Shares (viz. equity shares, convertibles etc.) Type of issuance (further public Qualified Institutions Placement offering, rights issue, depository receipts (ADR/GDR), qualified institutions placement, preferential allotment etc.) Total no. of securities issued or the total 1,98,67,549 Equity Shares to eligible amount for which the securities have qualified institutional buyers at the issue price been issued (approximately) of ₹ 755 per Equity Share, i.e., at a premium of ₹ 753 per Equity Share (which includes a discount of ₹ 16.73 (2.17% of the floor price) to the floor price), aggregating to approximately ₹ 15,000 million, pursuant to the proposed Issue. A certified copy of the resolution passed by the Finance & Investment Committee is enclosed for your information and records. The meeting of the Finance & Investment Committee commenced at 10:30 p.m. and concluded at 11:35 p.m. We request you to take the above on record and treat the same as compliance under the applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. Thanking you, For Krishna Institute of Medical Sciences Limited Nagajayanthi Juttur Raghavendra Das Company Secretary & Compliance office ANNEXURE A LIST OF ALLOTTEES WHO HAVE BEEN ALLOTTED MORE THAN 5% OF THE EQUITY SHARES ISSUED IN THE QUALIFIED INSTITUTIONS PLACEMENT Sr Name of the Allottees No. of Shares % of total No Allotted Equity Shares offered in the Issue 1 INTERNATIONAL FINANCE CORPORATION 19,86,755 10.00 2A SBI ELSS TAX SAVER FUND 13,24,503 6.67 2B SBI HEALTHCARE OPPORTUNITIES FUND 3,31,126 1.67 3 HDFC LIFE INSURANCE COMPANY LIMITED 13,24,503 6.67 4A KOTAK FLEXICAP FUND 10,73,921 5.41 4B KOTAK BALANCED ADVANTAGE FUND 1,43,190 0.72 4C KOTAK FOCUSED FUND 71,595 0.36 KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK SERVICES 35,797 0.18 4D FUND NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON POWER & 3,31,126 1.67 5A INFRA FUND NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA 9,93,377 5.00 5B SMALL CAP FUND 6A AXIS ELSS TAX SAVER FUND 10,18,849 5.13 AXIS MUTUAL FUND TRUSTEE LTD. A/C AXIS MUTUAL 1,01,884 0.51 6B FUND A/C AXIS MULTI ASSET ALLOCATION FUND AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL 2,03,770 1.03 6C FUND A/C AXIS ESG INTEGRATION STRATEGY FUND POLAR CAPITAL FUNDS PLC - HEALTHCARE 13,21,996 6.65 7 OPPORTUNITIES FUND 8 ICICI PRUDENTIAL SMALLCAP FUND 10,26,490 5.17 9 KOTAK MAHINDRA LIFE INSURANCE COMPANY LTD. 10,26,490 5.17 10 INVESCO INDIA SMALLCAP FUND 10,26,490 5.17 CERTIFIED TRUE EXTRACTS OF THE RESOLUTION APPROVED BY THE 22ND FINANCE & INVESTMENT COMMITTEE OF THE BOARD OF DIRECTORS OF KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED IN ITS MEETING HELD AT 10:30 PM ON FRIDAY, 19th JUNE, 2026 AT 4TH FLOOR, BLOCK III, KIMS HOSPITAL, #1-8-31/1, MINISTERS ROAD, SECUNDERABAD – 500003 Allotment of equity shares pursuant to qualified institutions placement “RESOLVED THAT the allotment of 19,867,549 equity shares of face value ₹ 2 each (the “Equity Shares”) at a price of ₹ 755 per Equity Share, including a premium of ₹ 753 per equity share and reflects a discount of 2.17 % on the Floor Price, i.e., ₹ 771.73 per Equity Share, aggregating to ₹ 15,000 million to the successful qualified institutional buyers, as per the list enclosed in Annexure A, and pursuant to Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the “SEBI ICDR Regulations”), Section 42 and Section 62 of the Companies Act, 2013, read with Rule 14 of the Companies (Prospectus and Allotment of Securities) Rules, 2014 made thereunder, each as amended (“Companies Act”), and the provisions of all other applicable laws, rules and regulations, guidelines, circulars, and notifications and pursuant to the resolution passed by the board of directors of the Company at its meeting held on March 11,2026 ,and the special resolution passed by the shareholders of the Company by way of postal ballot on April 15, 2026, authorizing the issue of Equity Shares, the placement agreement dated June 16,2026 ,the memorandum of association and articles of association of the Company, preliminary placement document dated June 16,2026, and the placement document dated June 19, 2026, against receipt of full payment of application monies in the escrow account, in accordance with the details specified in the Confirmation of Allocation Note and application form for the Issue, be and is hereby approved.” “RESOLVED FURTHER THAT the Equity Shares allotted as above shall, subject to the provisions of the memorandum and articles of association of the Company, rank pari passu with the existing Equity Shares of the Company and be entitled to such dividends and corporate benefits, if any, declared by the Company after the allotment and in compliance with the Companies Act, Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, and other applicable laws and regulations.” “RESOLVED FURTHER THAT the consent and approval of this Finance and Investment Committee be and is hereby accorded for filing with the National Stock Exchange of India Limited and the BSE Limited, the details of the allottees who have been allotted Equity Shares equal to or more than 5% of the Issue size, a list of which was circulated to this Finance and Investment Committee and initialled by Dr. Bhaskar Rao Bollineni, Chaiman and Managing Director for identification/ placed before this meeting. “RESOLVED FURTHER THAT the above Equity Shares be issued to the allottees in dematerialized form and be credited to the respective demat accounts of the successful bidders in dematerialized form, and that the application be mad [Showing first 8,000 characters — download PDF for full document]